Back
Boston Scientific Corporation (BSX)
Health CareBSX · NEW YORK STOCK EXCHANGE, INC. · USD
New to investing? How to read this page →$44.77
−0.48%Price · 1 year
Loading live analysis…
Loading analysis…
Intrinsic Investor is for education and research only — not financial advice.
Key metrics
EPS
$1.94
ROE
14.7%
Gross margin
68.9%
Debt/Equity
0.42x
Revenue growth
11.6%
Boston Scientific Corporation — company intelligence
Earnings surprises
Q1 2026$0.80 vs $0.79 est+0.7%
Q4 2025$0.80 vs $0.79 est+1.6%
Q3 2025$0.75 vs $0.72 est+4.1%
Q2 2025$0.75 vs $0.73 est+2.5%
Insider activity · 90 days
18 buys3 sellsnet +47,649 shares
Monson Jonathanother 2,087 · Jul 1, 2026
Monson JonathanSell 1,010 · Jul 1, 2026
Mahoney Michael Fgift 386,755 · May 28, 2026
Recent SEC filings
4 — Insider transaction reportJul 2, 2026
4 — Insider transaction reportJun 1, 2026
4 — Insider transaction reportMay 21, 2026
Latest news
Is It Worth Investing in Boston Scientific (BSX) Based on Wall Street's Bullish Views? — Yahoo · 21h ago
'Selling Winners, Buying Losers': Tech Stocks Drop as Energy Jumps to Start H2 — Benzinga · 1d ago
The Wide Chasm Priced Into Boston Scientific Stock — Yahoo · 1d ago
J&J wins FDA approval for dual-energy ablation catheter — Yahoo · 2d ago
AI Valuation Narrative
Generates a short bull / bear / catalyst summary from the analytics we already computed. No target prices. Research tool, not investment advice.
Explore more
Peers & similar stocks
Quick links to related tickers for research.
About Boston Scientific Corporation
Weekly undervalued picks (like BSX)
Get 3 new value ideas and the fair-value math behind them every week. One email, unsubscribe anytime.
Free. No spam. We only email once per week.
Data is provided "as-is" and may be delayed or incomplete. Intrinsic Investor is for education only and is not investment advice.